Finally, in 2020, Kojima et al. published a study in the ESC Heart Failure journal, which aimed to assess the usefulness of the HGF in 34 patients with Fontan circulation (mean age 59.3 ± 7.9 months) [107]. Here, HGF is linked to heart failure.